Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma.

High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma. J Neurooncol. 1998 Apr; 37(2):169-76.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.